Spending on medicines grew less than one percent in 2017
By Holly Campbell | April 19, 2018
Last year, a record number of new treatments and cures that are transforming care for patients fighting debilitating diseases like cancer, hepatitis C, high cholesterol and more were approved by...
Read More
Patients pay the price when hospitals mark up cancer medicines
By Joe Vandigo | April 5, 2018
Two studies released last month reveal how hospitals across the country mark up the price of medicines and deliver a growing share of provider-administered medicines, resulting in higher costs...
Read More
A new era in cancer
By Andrew Powaleny | November 1, 2017
The last few years have seen unparalleled progress in cancer care, with breakthrough research driving major advances in diagnosis and treatment. Next week, on Wednesday, November 8, leading minds...
Read More
PhRMA, member companies and NIH create public-private partnership for immuno-oncology
By Andrew Powaleny | October 12, 2017
The rapid pace of scientific advances has helped usher in a new era of medicine for cancer patients over the last decade. This morning, the National Institutes of Health (NIH) took a significant...
Read More
What they are saying: Study on cancer R&D costs is not an accurate representation of marketplace
By Holly Campbell | September 12, 2017
This post has been updated as of 10/2/2017 A recent study published in JAMA Internal Medicine provides flawed and inaccurate estimates of the significant research and development (R&D) investments...
Read More
Protect your health: Important disaster preparedness tips for Harvey and Irma
By Guest Contributor | September 6, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Medicare Monday: New report highlights progress in fighting cancer with new physician-administered medicines
By Nicole Longo | June 12, 2017
We’ve seen significant progress in recent years in the treatment of cancer, and that progress is expected to continue. A new report released this month found that there are more than 240 new...
Read More
More than 240 immuno-oncology treatments in development to fight cancer
By Andrew Powaleny | June 1, 2017
The American Cancer Society estimates that in 2017 alone, there will be more than 1.6 million new cases of cancer and 600,000 cancer deaths in the United States. With estimates like these, the...
Read More
Medicines have significantly increased chances of cancer survival around the globe
By Amey Sutkowski | May 24, 2017
Since a peak in 1991, cancer mortality rates have declined by as much as 27% around the world. These gains in cancer survival are largely attributed to new and innovative therapies. According to...
Read More
Fighting disease Together: New ads feature patients and the researchers behind today’s breakthroughs
By Robert Zirkelbach | April 19, 2017
Today, we launched our next wave of advertising as part of the GOBOLDLY™ campaign, titled Together, featuring the stories of researchers developing cutting-edge breakthroughs alongside patients...
Read More
Medicare Monday (100)
340B Spotlight (33)
Cost & Consequence (0)
